Cancer Research AACR Conference on Molecular Diagnostics - 2008  Cancer Health Disparities Conference 2009
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Maletínská, L.
Right arrow Articles by Forte, T. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Maletínská, L.
Right arrow Articles by Forte, T. M.
[Cancer Research 60, 2300-2303, April 15, 2000]
© 2000 American Association for Cancer Research


Tumor Biology

Human Glioblastoma Cell Lines: Levels of Low-Density Lipoprotein Receptor and Low-Density Lipoprotein Receptor-related Protein1

Lenka Maletínská, Eleanor A. Blakely, Kathleen A. Bjornstad, Dennis F. Deen, Laura J. Knoff and Trudy M. Forte2

Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California 94720 [L. M., E. A. B., K. A. B., L. J. K., T. M. F.], and Brain Tumor Research Center, University of California, San Francisco, California 94143 [D. F. D.]

The status of the low-density lipoprotein (LDL) receptor and LDL receptor-related protein (LRP) in seven human glioma cell lines was evaluated to extend our knowledge of human glioblastoma multiforme tumor metabolism for future drug design. Cell lines SF-767, SF-763, A-172, U-87 MG, U-251 MG, U-343 MG, and SF-539 were used. Binding of 125I-labeled LDL to these cells at 4°C was carried out to determine the number of LDL receptors on cells and the affinity of LDL for these receptors. The content of LRP was measured by immunoblotting. The presence of specific saturable LDL receptors was proven in six of the cell lines investigated. SF-767 cells revealed high-affinity LDL binding (equilibrium dissociation constant, Kd = 7 nM) and maximum binding capacity approximating 300,000 receptors/cell. Most of the remaining cell lines had relatively lower affinity (Kd = 38–62 nM) but also had very high numbers of receptors (128,000–950,000/cell). All cell lines exhibited LRP, but the expression was variable. The cell lines SF-539, U-87 MG, and U-343 MG were particularly rich in this protein. The data suggest that glioblastoma cells have high numbers of LDL receptors; however, there is considerable variation in binding affinity. Overall, this finding suggests that LDL receptors on glioblastoma cells could potentially be useful for targeting antitumor agents. LRP, a multifunctional receptor expressed on glioblastoma cells, also has the possibility for serving as a therapeutic target.




This article has been cited by other articles:


Home page
Cancer Res.Home page
S. Amos, M. Mut, C. G. diPierro, J. E. Carpenter, A. Xiao, Z. A. Kohutek, G. T. Redpath, Y. Zhao, J. Wang, M. E. Shaffrey, et al.
Protein Kinase C-{alpha} Mediated Regulation of Low-Density Lipoprotein Receptor Related Protein and Urokinase Increases Astrocytoma Invasion
Cancer Res., November 1, 2007; 67(21): 10241 - 10251.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
J. Su, L. He, N. Zhang, and P. C. Ho
Evaluation of Tributyrin Lipid Emulsion with Affinity to Low-Density Lipoprotein: Pharmacokinetics in Adult Male Wistar Rats and Cellular Activity on Caco-2 and HepG2 Cell Lines
J. Pharmacol. Exp. Ther., January 1, 2006; 316(1): 62 - 70.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
P. M. Smith, A. Cowan, and B. A. White
The Low-Density Lipoprotein Receptor Is Regulated by Estrogen and Forms a Functional Complex with the Estrogen-Regulated Protein Ezrin in Pituitary GH3 Somatolactotropes
Endocrinology, July 1, 2004; 145(7): 3075 - 3083.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
Y. Zhu, H. Bujo, H. Yamazaki, K. Ohwaki, M. Jiang, S. Hirayama, T. Kanaki, M. Shibasaki, K. Takahashi, W. J. Schneider, et al.
LR11, an LDL Receptor Gene Family Member, Is a Novel Regulator of Smooth Muscle Cell Migration
Circ. Res., April 2, 2004; 94(6): 752 - 758.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
Y. Li, J. M. Knisely, W. Lu, L. M. McCormick, J. Wang, J. Henkin, A. L. Schwartz, and G. Bu
Low Density Lipoprotein (LDL) Receptor-related Protein 1B Impairs Urokinase Receptor Regeneration on the Cell Surface and Inhibits Cell Migration
J. Biol. Chem., October 25, 2002; 277(44): 42366 - 42371.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2000 by the American Association for Cancer Research.